Rezolute Inc (RZLT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $353.54M
Last updated: Nov 17, 2026 at 11:06 AM ET
Rezolute Inc (RZLT) Financials: Revenue, Profit and Cash Flow
Rezolute reported revenue of $0 for the fiscal year ended Jun 30, 2026. That year, net income was -$77.59M and operating cash flow was -$64.64M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$18.49M.
Revenue and Margins
The company reported no revenue in the fiscal year ended Jun 2026, with an operating loss of $82.97M.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $0 | N/A | N/A | N/A | N/A |
| Jun 2025 | $0 | N/A | N/A | N/A | N/A |
| Jun 2024 | $0 | N/A | N/A | N/A | N/A |
| Jun 2023 | $0 | N/A | N/A | N/A | N/A |
| Jun 2022 | $0 | N/A | N/A | N/A | N/A |
| Jun 2021 | $0 | N/A | N/A | N/A | N/A |
| Jun 2020 | $0 | N/A | N/A | N/A | N/A |
| Jun 2019 | $0 | N/A | N/A | N/A | N/A |
| Jun 2018 | -$2.61M | N/A | N/A | N/A | N/A |
| Jun 2017 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Jun 2026, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.61M | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $8.26M | $21.46M | $20.19M | $14.30M |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | -$8.26M | -$21.46M | -$22.80M | -$14.30M |
| Research and development | $53.80M | $61.53M | $55.74M | $43.81M | $32.49M | $14.99M | $3.21M | $674.00K | $17.28M | $12.86M |
| Operating income | -$82.97M | -$79.89M | -$70.42M | -$55.99M | -$41.84M | -$22.89M | -$20.52M | -$25.94M | -$55.11M | -$40.65M |
| Net income | -$77.59M | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.90M | -$20.33M | -$30.45M | -$29.86M | -$20.28M |
| EBITDA | N/A | N/A | N/A | N/A | -$35.05M | -$20.58M | -$20.50M | -$23.84M | -$54.02M | -$39.52M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | N/A | $0 | $0 | $0 | $46.00K | $0 | $0 | $0 | $58.00K | $0 | $0 |
| Gross profit | $0 | N/A | $0 | $0 | $0 | -$8.00K | $0 | $0 | $0 | $51.00K | $0 | $0 |
| Operating income | -$19.39M | -$21.56M | -$17.37M | -$24.22M | -$19.82M | -$25.85M | -$20.02M | -$17.08M | -$16.94M | -$23.10M | -$16.21M | -$15.19M |
| Net income | -$18.49M | -$20.49M | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | -$15.73M | -$15.38M | -$22.98M | -$17.05M | -$13.91M |
Balance Sheet
As of Jun 2026, cash and equivalents of $10.62M were 9.4% of total assets of $112.85M, against total liabilities of $12.16M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $112.85M | $175.49M | $132.74M | $123.72M | $152.42M | $42.61M | $10.96M | $12.25M | $2.50M | $10.63M |
| Current assets | $110.51M | $171.15M | $128.65M | $104.91M | $152.10M | $41.99M | $10.52M | $12.14M | $2.01M | $4.93M |
| Cash and equivalents | $10.62M | $94.11M | $70.40M | $16.04M | $150.41M | $41.05M | $9.96M | $11.57M | $1.65M | $4.49M |
| Total liabilities | $12.16M | $13.36M | $11.73M | $7.55M | $2.95M | $16.51M | $3.60M | $10.50M | $6.46M | $2.10M |
| Short-term debt | N/A | $632.00K | $568.00K | $541.00K | $108.00K | $265.00K | $245.00K | $10.00K | $3.44M | $10.00K |
| Long-term debt | N/A | N/A | N/A | N/A | $407.00K | $13.97M | N/A | N/A | N/A | N/A |
| Shareholder equity | $100.69M | $162.13M | $121.00M | $116.17M | $149.47M | $26.10M | $7.37M | $1.75M | -$3.96M | $8.53M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $96.01M | $112.85M | $125.46M | $138.63M | $158.66M | $175.49M | $94.74M | $112.01M | $123.41M | $132.74M | $87.74M | $102.15M |
| Total liabilities | $10.06M | $12.16M | $8.63M | $10.63M | $11.50M | $13.36M | $12.17M | $12.42M | $9.97M | $11.73M | $16.88M | $10.42M |
| Cash and equivalents | $8.15M | $10.62M | $11.24M | $11.94M | $9.10M | $94.11M | $14.60M | $8.93M | $10.47M | $70.40M | $5.93M | $12.50M |
| Shareholder equity | $85.95M | $100.69M | $116.83M | $128.00M | $147.17M | $162.13M | $82.57M | $99.59M | $113.44M | $121.00M | $70.86M | $91.73M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Jun 2026.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$64.64M | -$69.08M | -$57.37M | -$44.48M | -$39.62M | -$20.44M | -$24.17M | -$15.30M | -$14.11M | -$13.31M |
| Capital expenditures | N/A | $0 | $0 | $153.00K | $0 | $153.00K | $153.00K | $47.00K | $6.00K | $407.93K |
| Free cash flow | N/A | -$69.08M | -$57.37M | -$44.63M | -$39.62M | -$20.59M | -$24.32M | -$15.35M | -$14.12M | -$13.72M |
| Share repurchases | $35.00K | $1.06M | $318.00K | $0 | N/A | N/A | $1.50M | $0 | $60.00K | $683.19K |
| Investing cash flow | -$21.10M | -$14.54M | $48.70M | -$101.46M | $0 | $0 | $0 | $231.00K | $1.73M | -$195.38K |
| Financing cash flow | $2.24M | $107.33M | $63.03M | $11.57M | $148.98M | $51.53M | $22.55M | $25.00M | $9.54M | $13.93M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$18.78M | -$13.15M | -$13.73M | -$20.32M | -$17.43M | -$22.00M | -$17.40M | -$13.67M | -$16.01M | -$18.52M | -$15.24M | -$13.02M |
| Free cash flow | N/A | N/A | -$13.73M | -$20.32M | -$17.43M | -$22.00M | -$17.40M | -$13.67M | -$16.01M | -$18.52M | -$15.24M | -$13.02M |
Frequently Asked Questions About RZLT
What is Rezolute's annual revenue?
Rezolute reported revenue of $0 for the fiscal year ended Jun 30, 2026.
Is Rezolute profitable?
No. Rezolute reported net income of -$77.59M for the fiscal year ended Jun 30, 2026.
How much debt does Rezolute have?
The balance sheet dated Jun 30, 2026 reported cash and equivalents of $10.62M.
RZLT pages: Overview, Earnings, Forecast, Financials, Competitors